{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-020579","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.130897+00:00","generated_at":"2026-05-19T04:28:36.920743+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Aytu BioPharma posts updated investor presentation highlighting EXXUA opportunity","bullets":["Presentation posted on June 17, 2025 for use in upcoming investor meetings.","Highlights EXXUA™ (gepirone) extended-release tablets as a key pipeline asset.","No new financial guidance, operational metrics, or material events disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-020579","json":"https://secwatch.observer/filing/0001437749-25-020579.json","markdown":"https://secwatch.observer/filing/0001437749-25-020579.md","text":"https://secwatch.observer/filing/0001437749-25-020579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925020579/0001437749-25-020579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925020579/aytu20250616_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:28:36.920743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}